This EIS 2025 Outlook describes key developments and challenges expected to shape the insurance landscape in the coming year.
Explore how these trends impact operations, strategy, and customer engagement to stay competitive in 2025 and beyond.
Press Release
EIS, a core and digital platform provider for leading insurers, commemorated the one-year anniversary of the expansion of its core EIS Suite™ to carriers in the life and annuities markets by announcing a slate of new life insurance products with a host of industry-leading features, two United States national insurers already implementing the products and additional insurers in APAC, UK and EMEA in proof-of-concept or other buying cycle stages.
Since announcing its life and annuities launch in February of 2021, EIS’ fast-track development methodology drove a rollout of new capabilities covering major product segments, including Group Universal Life, Group Whole Life, and Group Term Life.
The EIS Suite of life offerings provides carriers with a broad range of innovative microservice features, a high degree of agent, service, and customer usability through dedicated persona-based applications, out-of-the-box templates, reusable content, and flexible low code/no code tools. Innovative features include:
“Timing is everything and the extremely positive market response to our entry and offering is all about addressing today’s needs,” says Samantha Chow, Global Market Lead for LA&H at EIS. “To attract and retain top talent, in the great resignation era, employers are turning to workplace benefits insurers to help them create more competitive packages. It is a huge challenge for insurers to add new products and product types they don’t currently have in their coverage libraries. Insurance providers today may offer individual life, but want to enter the growing market of group and are unable due to legacy constraints.”
“With our expertise in the workplace benefits market, we are well-positioned with a market-ready, scalable solution that solves carriers’ challenges entering this new market or creating products they wouldn’t have offered in the past,” concluded Samantha Chow.
Robert McIsaac, head of Life, Annuities and Benefits at analyst firm Aite-Novarica Group commented: “Carriers in the life, annuities and benefits lines of business generally find that strong support for cash accumulation products is a critical component on their modernization journey toward supporting future state business models. Capabilities such as what EIS is adding now provide an expanded set of options for carriers to consider as they make potentially once-in-a-generation investment decisions for supporting long liability tail businesses.”
Throughout 2021, analyst firms globally have recognized the growth and strength of EIS’ coretech solution for the life and annuities industry within their reports.
EIS was named:
In the last year, EIS has more than doubled its product and R&D teams dedicated to life. That investment is already paying dividends with two new national account carriers in the US currently implementing EIS’ universal life and whole life solutions.
“As we embark on 2022,” added Chow, “we are looking forward to building on our life capabilities, including individual life products and annuities, and introducing the unique value of our high-velocity platform to additional forward-looking life insurance companies.”
*Gartner, Magic Quadrant for Life Insurance Policy Administration Systems, North America, 10 August 2021, By Richard Natale, Rajesh Narayan
GARTNER and Magic Quadrant are registered trademarks and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.